Vitamins for Eczema: What Vitamin E and Combination Trials Actually Tested
Vitamins for eczema are not a proven cure or a single treatment category. Small vitamin E and vitamin D-plus-E trials reported symptom improvements, but they tested specific protocols, not every multivitamin. Short-term improvement also did not establish protection against later relapse. This page compares those experiments; the doses below describe research, not instructions to take supplements.
Vitamin D/E trial · Vitamin E trial · Sources checked September 25, 2026.
One vitamin, two vitamins, or a multivitamin?
A randomized, double-blind trial included 45 people with atopic dermatitis for 60 days. Its four groups received matching placebos (11 people), vitamin D3 at 1,600 IU plus vitamin E placebo (12), synthetic all-rac-alpha-tocopherol at 600 IU plus vitamin D placebo (11), or both active vitamins (11). The researchers assessed SCORAD, an eczema-severity measure, and reported improvement in the active groups.
The design matters more than a list of ingredients: it included separate vitamin arms and a specified combination. It was not a trial of a general multivitamin. Our interpretation is limited to that distinction; a combination result cannot be transferred to an untested blend or used to identify which component caused an individual person’s response. The small groups and short observation window remain part of the evidence.
Original randomized trial: methods and results · Sources checked September 25, 2026.
Improved symptoms did not mean fewer later relapses
A separate randomized, double-blind trial enrolled 70 participants with mild-to-moderate atopic dermatitis and compared vitamin E, 400 IU daily, with placebo for four months. Reported SCORAD changes were -11.12 with vitamin E and -3.89 with placebo. The investigators reported greater improvement for the assessed symptoms except sleeplessness.
Three months after treatment ended, the recurrence assessment involved 42 remaining participants and found no statistically significant difference between groups. The treatment-period result and the later recurrence result answer different questions. The follow-up group was smaller than the original enrollment; describing the relapse assessment as including everyone randomized would overstate it. This report does not establish lasting control after supplementation stops.
Original vitamin E trial: abstract · Sources checked September 25, 2026.
The unit and formulation belong beside the dose
NIH explains that vitamin E activity depends on its form: natural and synthetic vitamin E do not use the same conversion between international units and milligrams. That makes the formulation a necessary part of a trial record. A bottle marked in milligrams cannot be compared with an IU-based protocol by matching the printed number alone.
Our comparison keeps the two trial protocols separate. It does not rank them by dose: their formulations, patient groups and durations cannot be treated as interchangeable. A higher number on a label is not evidence of greater eczema benefit.
NIH vitamin E: forms and measurement · Sources checked September 25, 2026.
A short trial cannot certify a supplement as harmless
NIH describes medication interactions and warns that high-dose vitamin E can increase bleeding risk, including with anticoagulant or antiplatelet medicines. A small eczema trial’s safety observations cannot rule out uncommon harms or settle safety for someone taking those medicines. Supplement decisions require review of the actual formulation and the person’s treatment history.
For these vitamin claims, keep two dated outcomes on the evidence record: what happened during treatment and what happened after it stopped. If follow-up is missing, record it as missing. A favorable skin score at the end of a trial does not fill that blank.
NIH vitamin E: safety and interactions · Vitamin E follow-up · Sources checked September 25, 2026.
Reviewed September 25, 2026. Educational analysis; not individualized medical advice.
Ingredient evidence: vitamin D · fish oil · probiotics.